Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 26, Issue 5, 1999, Pages 619-629

  Arima, N ^a   Mizoguchi, H ^a   Shirakawa, S ^a   Tomonaga, M ^a   Takatsuki, K ^a   Ohno, R ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DRUG DERIVATIVE; FLUDARABINE PHOSPHATE; VIDARABINE PHOSPHATE;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CHEMICALLY INDUCED DISORDER; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG SCREENING; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; T CELL LYMPHOMA; THROMBOCYTOPENIA;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BLOOD CELL COUNT; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGED; NEUTROPENIA; THROMBOCYTOPENIA; VIDARABINE PHOSPHATE;

EID: 0033109624     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)